Maria Tretiakova

18.1k total citations · 3 hit papers
177 papers, 10.4k citations indexed

About

Maria Tretiakova is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Maria Tretiakova has authored 177 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 74 papers in Pulmonary and Respiratory Medicine and 44 papers in Surgery. Recurrent topics in Maria Tretiakova's work include Renal and related cancers (43 papers), Renal cell carcinoma treatment (42 papers) and Cancer Genomics and Diagnostics (19 papers). Maria Tretiakova is often cited by papers focused on Renal and related cancers (43 papers), Renal cell carcinoma treatment (42 papers) and Cancer Genomics and Diagnostics (19 papers). Maria Tretiakova collaborates with scholars based in United States, Canada and Germany. Maria Tretiakova's co-authors include Thomas Krausz, Olufunmilayo I. Olopade, Ximing J. Yang, Ravi Salgia, Aliya N. Husain, Chad Livasy, Rita Nanda, Charles M. Perou, Dominic T. Moore and Gamze Karaca and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Maria Tretiakova

166 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

2005 839 citations Maria Tretiakova et al. Modern Pathology profile →
Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease

2004 647 citations Bertrand Meresse, Cezary Ciszewski et al. profile →
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

2021 170 citations Maria Tretiakova et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Tretiakova United States	54	4.5k	3.4k	3.0k	2.1k	1.5k	177	10.4k
Kazuaki Takabe United States	60	7.0k 1.6×	2.3k 0.7×	4.3k 1.5×	2.8k 1.4×	1.3k 0.8×	398	12.6k
Yung‐Ming Jeng Taiwan	65	6.0k 1.4×	1.8k 0.5×	4.4k 1.5×	2.6k 1.2×	2.5k 1.7×	308	13.3k
Generoso Bevilacqua Italy	49	5.5k 1.2×	2.1k 0.6×	3.8k 1.3×	1.9k 0.9×	963 0.6×	283	10.3k
Kenneth J. Hillan United States	36	9.0k 2.0×	2.5k 0.7×	4.2k 1.4×	3.0k 1.5×	1.3k 0.8×	57	14.6k
Peter Birner Austria	49	3.3k 0.7×	2.1k 0.6×	4.0k 1.3×	2.2k 1.1×	1.2k 0.8×	169	9.0k
Silvano Bòsari Italy	56	4.6k 1.0×	1.7k 0.5×	2.8k 1.0×	2.5k 1.2×	1.4k 0.9×	189	9.4k
Robert S. Warren United States	43	3.5k 0.8×	1.1k 0.3×	3.9k 1.3×	1.5k 0.7×	1.3k 0.9×	123	8.7k
Vivek Mittal United States	50	7.2k 1.6×	1.5k 0.5×	4.2k 1.4×	3.2k 1.5×	1.4k 0.9×	130	12.9k
Massimo Roncalli Italy	59	3.2k 0.7×	3.3k 1.0×	4.7k 1.6×	1.8k 0.9×	1.8k 1.2×	228	11.5k
Arthur Liberzon United States	12	7.1k 1.6×	2.4k 0.7×	2.5k 0.9×	3.1k 1.5×	744 0.5×	17	12.0k

Countries citing papers authored by Maria Tretiakova

Since Specialization

Citations

This map shows the geographic impact of Maria Tretiakova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Tretiakova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Tretiakova more than expected).

Fields of papers citing papers by Maria Tretiakova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Tretiakova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Tretiakova. The network helps show where Maria Tretiakova may publish in the future.

Co-authorship network of co-authors of Maria Tretiakova

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Tretiakova. A scholar is included among the top collaborators of Maria Tretiakova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Tretiakova. Maria Tretiakova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papanicolau‐Sengos, Antonios, Kyung Park, Matija Snuderl, et al.. (2025). DNA Methylation-Based Classification of Kidney Neoplasms. Modern Pathology. 38(11). 100884–100884.

Lee, Hyun Jung, et al.. (2025). Diagnostic accuracy of TRIM63 RNA-ISH in MiTF-rearranged renal cell carcinomas: Results from a 331-tumor validation cohort. Human Pathology. 161. 105862–105862. 3 indexed citations

Wright, Jonathan L., Funda Vakar‐Lopez, Maria Tretiakova, et al.. (2024). Outcome Analysis of a Series of Mixed-Grade, Non-muscle Invasive, Papillary Carcinomas of the Bladder. International Journal of Surgical Pathology. 33(1). 19–25. 1 indexed citations

Tretiakova, Maria, et al.. (2024). Metastatic SMARCB1-Deficient Renal Medullary Carcinoma without Hemoglobinopathy with Durable and Dramatic Response to Pembrolizumab plus Lenvatinib: Case Report. SHILAP Revista de lepidopterología. 17(1). 1025–1033. 1 indexed citations

Vakar‐Lopez, Funda, et al.. (2024). Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel. Human Pathology. 146. 43–48. 2 indexed citations

Patel, Radhika A., Ilsa Coleman, Martine P. Roudier, et al.. (2022). Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations. Cancer Research Communications. 2(5). 277–285. 5 indexed citations

Mostaghel, Elahe A., Ailin Zhang, Susana Hernández, et al.. (2018). Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(1). 426–439. 49 indexed citations

Tretiakova, Maria, Regan Fulton, Masha Kocherginsky, et al.. (2017). Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression. Modern Pathology. 31(4). 623–632. 93 indexed citations

Andeen, Nicole K. & Maria Tretiakova. (2015). Metastatic Treated Malignant Germ Cell Tumors. Applied immunohistochemistry & molecular morphology. 24(3). 210–214. 10 indexed citations

10.

Williams, James B., Diana Pang, Bertha Delgado, et al.. (2009). A Model of Gene-Environment Interaction Reveals Altered Mammary Gland Gene Expression and Increased Tumor Growth following Social Isolation. Cancer Prevention Research. 2(10). 850–861. 91 indexed citations

11.

Liu, Jiang, Murad Ghanim, Lei Xue, et al.. (2009). Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer. Science. 323(5918). 1218–1222. 98 indexed citations

12.

Kanteti, Rajani, Vidya Nallasura, Sivakumar Loganathan, et al.. (2009). PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Laboratory Investigation. 89(3). 301–314. 82 indexed citations

13.

Sawada, Kenjiro, Anirban Mitra, A. Reza Radjabi, et al.. (2008). Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target. Cancer Research. 68(7). 2329–2339. 303 indexed citations

14.

Puri, Neelu, Salman Ahmed, Varalakshmi Janamanchi, et al.. (2007). c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma. Clinical Cancer Research. 13(7). 2246–2253. 129 indexed citations

15.

Cohen, Greg, Reba Mustafi, Sandra Cerda, et al.. (2006). Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci. Cancer Research. 66(11). 5656–5664. 45 indexed citations

16.

Meresse, Bertrand, Shane A. Curran, Cezary Ciszewski, et al.. (2006). Reprogramming of CTLs into natural killer–like cells in celiac disease. The Journal of Experimental Medicine. 203(5). 1343–1355. 219 indexed citations

17.

Patrick, C., Ramasamy Jagadeeswaran, Simha Jagadeesh, et al.. (2005). Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer. Cancer Research. 65(4). 1479–1488. 467 indexed citations

18.

Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Maria Tretiakova, et al.. (2005). Inhibition of c-Met signaling by SU11274 in head and neck squamous cell carcinoma (HNSCC). Cancer Research. 65. 1405–1405. 2 indexed citations

19.

Huo, Lei, Jun Sugimura, Maria Tretiakova, et al.. (2005). C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Human Pathology. 36(3). 262–268. 77 indexed citations

20.

Iczkowski, Kenneth A., Zhiming Jiang, Maria Tretiakova, & Xiaofang Yang. (2003). Prostatic needle biopsies with suspicious diagnosis 80% Resolved using P504S/AMACR and keratin 34bE12 immunostaining. Modern Pathology. 16(1). 154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact